Learning To Achieve Wellness Inc - Medicare Mental Health Clinic in Brandon, FL

Learning To Achieve Wellness Inc is a medicare enrolled mental health clinic (Clinic/center - Mental Health (including Community Mental Health Center)) in Brandon, Florida. The current practice location for Learning To Achieve Wellness Inc is 413 W Robertson St, Brandon, Florida. For appointments, you can reach them via phone at (813) 999-1516. The mailing address for Learning To Achieve Wellness Inc is 413 W Robertson St, Brandon, Florida and phone number is (813) 999-1516.

Learning To Achieve Wellness Inc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1033849575. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (813) 999-1516.

Contact Information

Learning To Achieve Wellness Inc
413 W Robertson St
Brandon
FL 33511-5014
(813) 999-1516
(813) 336-8384

Mental Health Clinic Profile

Full NameLearning To Achieve Wellness Inc
SpecialityClinic/Center
Location413 W Robertson St, Brandon, Florida
Authorized Official Name and PositionLillian Ingram (OWNER)
Authorized Official Contact8139991516
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Learning To Achieve Wellness Inc
413 W Robertson St
Brandon
FL 33511-5014

Ph: (813) 999-1516
Learning To Achieve Wellness Inc
413 W Robertson St
Brandon
FL 33511-5014

Ph: (813) 999-1516

NPI Details:

NPI Number1033849575
Provider Enumeration Date06/16/2022
Last Update Date10/18/2023
Certification Date10/18/2023

Medicare PECOS Information:

Medicare PECOS PAC ID9234514464
Medicare Enrollment IDO20220923001265

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

Medical Identifiers

Medical identifiers for Learning To Achieve Wellness Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1033849575NPI-NPPES
102546400MedicaidFL

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
261QM0801XClinic/center - Mental Health (including Community Mental Health Center) (* (Not Available))Primary
363LP0808XNurse Practitioner - Psychiatric/mental Health (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Learning To Achieve Wellness Inc acts as a billing entity for following providers:
Provider NameHany B Mikhail
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1013014737
PECOS PAC ID: 7315046588
Enrollment ID: I20070628000559

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

Provider NameLeo V Yason
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1417949140
PECOS PAC ID: 0749328185
Enrollment ID: I20091105000246

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

Provider NameLillian Ingram
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1942564711
PECOS PAC ID: 1759520349
Enrollment ID: I20130611000518

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

Provider NameJessica L Faber
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1043828536
PECOS PAC ID: 1951728021
Enrollment ID: I20200903001709

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

Provider NameBettina B Smith
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1245980655
PECOS PAC ID: 5496132748
Enrollment ID: I20220506001682

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

Provider NameGennifer M Young
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1326774977
PECOS PAC ID: 9133505142
Enrollment ID: I20220928002844

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

Provider NameJessica Burton
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1225722911
PECOS PAC ID: 8123474632
Enrollment ID: I20231019001361

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

Provider NameTangela D Ewin
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1295417806
PECOS PAC ID: 2961858105
Enrollment ID: I20231025000666

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

Provider NameRaquel Leilani Santos
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1184405060
PECOS PAC ID: 3274981832
Enrollment ID: I20231121002115

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

Provider NameHeather Marie Johnson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1487426078
PECOS PAC ID: 9234588005
Enrollment ID: I20231206001049

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

Provider NameAmanda Gail Torres
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1811521768
PECOS PAC ID: 6709274921
Enrollment ID: I20231212004132

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

Provider NameAshley Elizabeth Jones
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1861869448
PECOS PAC ID: 2163874074
Enrollment ID: I20240116004091

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

Provider NameMaureen A Yates
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1982098661
PECOS PAC ID: 5496198673
Enrollment ID: I20240205001557

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more Medical News

› Verified 9 days ago

News Archive

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.

Young, Black patients at higher risk of death in the first year after a heart transplant

Young, Black adults are more than twice as likely to die in the first year after a heart transplant when compared to same-age, non-Black heart transplant recipients, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

Tips to prevent injuries during winter season

"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."

Erivedge drug shows promise against advanced basal cell carcinoma

It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.

Read more News

› Verified 9 days ago

Clinic/Center in Brandon, FL

Paul Weisemann Professional Christian Counseling Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 138 E Bloomingdale Ave, Brandon, FL 33511
Phone: 813-643-2600    Fax: 813-643-2600
Rbh And Associates Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1463 Oakfield Dr, Suite #132, Brandon, FL 33511
Phone: 813-784-5617    
Ellie Mental Health
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 109 N Oakwood Ave Ste 105, Brandon, FL 33510
Phone: 904-704-7575    
Tampa Bay Neurology Clinic Inc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 613 Medical Care Dr, Brandon, FL 33511
Phone: 813-661-2211    Fax: 813-661-2212
Mindful And Present Counseling, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1219 Millennium Pkwy Ste 116, Brandon, FL 33511
Phone: 813-455-8672    
Behavior Analysis Next Door, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2527 Edgewater Falls Dr, Brandon, FL 33511
Phone: 561-319-6697    
Sheena Baker Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1219 Millennium Pkwy Ste 109, Brandon, FL 33511
Phone: 405-808-4900    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.